The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
Página oficial de la convocatoria ↗
This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials.
This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (RFA-DK-28-214).
Historial de cambios
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 04 Nov 2026 · af112cde21f4
- 22 Oct 2026 · 8172af0e8ba2
- 22 Oct 2026 · eb2213dbfacf
- 21 Oct 2026 · 74b206379dee
- 20 Oct 2026 · 014602ee1df6
- 19 Oct 2026 · 4bb419a73ce3
- 18 Oct 2026 · 77e0ea5cf3e9
- 17 Oct 2026 · f59ffe433976
- 16 Oct 2026 · 746e5f84a18e
- 15 Oct 2026 · ea0c457c7948
- 14 Oct 2026 · a7bed69c6302
- 13 Oct 2026 · be589c075929
- 12 Oct 2026 · f59ffe433976
- 11 Oct 2026 · 911c58d7a938
- 10 Oct 2026 · 409c62381000
- 09 Oct 2026 · dc6416bb9ba9
- 08 Oct 2026 · 8dacdb4bb972
- 07 Oct 2026 · 5f2da909d7e5
- 06 Oct 2026 · 0e99f36d51d0
- 05 Oct 2026 · 9089784c1ece